Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin type A for painful diabetic polyneuropathy
IRCT20190129042540N1Phase 3Completed
- Sponsor
- Rafsanjan University of Medical Sciences
- Start
- Feb 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of botulinum toxin type A in diabetic polyneuropathy (DPN), sponsored by Rafsanjan University of Medical Sciences. Started Feb 2018; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
diabetic polyneuropathy (DPN)
Beyond the preview
Go deeper on IRCT20190129042540N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190129042540N1.